GPT and Alzheimer disease: Our study aimed to address this knowledge gap by investigating the association of APOE ε4 carrier status and blood liver enzymes, including AST, ALT, the AST to ALT ratio, ALP, total bilirubin, and albumin, with AD diagnosis, AD biomarkers, and cognitive performance, in two independent cohorts.